心血管风险评分可评估ADVANCE日本队列中老年血友病患者的动脉血栓风险
ADVANCE Japan前瞻性队列纳入599例≥40岁血友病患者,5年随访中28例(4.67%)发生首次动脉事件。Hisayama模型和Suita评分预测的5年发生率与实际观察(每100例5年2.93次事件)接近,而QRISK3明显高估风险。加入血友病相关临床因素未提升预测性能,日本人群模型或可支持一级预防策略制定。
要点
- Hisayama模型和Suita评分对血友病患者5年动脉事件预测校准良好,QRISK3高估风险
- Hisayama模型灵敏度70.5%、特异度68.0%,或可支持日本血友病成人一级预防策略
- 加入血友病相关临床因素未改善现有风险评分的预测性能
核心结论
- 日本≥40岁血友病成人5年动脉事件发生率为4.67%,与日本一般人群预期相当。
- Hisayama模型和Suita评分能较好预测5年动脉事件风险,QRISK3明显高估风险。
- 加入血友病相关临床因素未提升现有评分的预测性能。
研究设计与样本
- ADVANCE Japan为日本全国性前瞻性注册研究,纳入≥40岁血友病成人。
- 分析599例参与者5年随访数据,排除既往动脉血栓者。
- 用Hisayama模型、Suita评分和QRISK3估计5年动脉事件风险,以灵敏度、特异度和观察/预期事件比较评估模型性能。
主要发现
- 599例参与者中位年龄59岁,血友病A占83%,重型占63%。
- 5年随访期间发生28例首次动脉事件(4.67%)。
- 识别事件的灵敏度和特异度分别为:Hisayama模型70.5%和68.0%,Suita评分73.3%和61.2%,QRISK3 71.4%和57.7%。
- 观察发生率为每100例参与者5年2.93次事件,与Hisayama模型和Suita评分预测接近,QRISK3明显高估。
关键数值与推荐
- Hisayama模型灵敏度70.5%、特异度68.0%。
- Suita评分灵敏度73.3%、特异度61.2%。
- QRISK3灵敏度71.4%、特异度57.7%。
- 观察发生率每100例参与者5年2.93次事件。
临床怎么用
- 对日本≥40岁血友病成人,可考虑用Hisayama模型或Suita评分进行动脉血栓风险分层以支持一级预防。
- QRISK3在此人群明显高估风险,不宜直接用于风险沟通或治疗决策。
- 加入血友病相关临床因素未改善预测,现有评分已可提供参考。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As the life expectancy of individuals with hemophilia increases, arterial thrombotic disease has emerged as an important clinical issue. Accurate risk stratification for primary prevention is increasingly critical, because managing arterial events is complex in hemophilia owing to bleeding risk. However, current prospective data on event incidence and risk prediction for hemophilia remain limited. We analyzed 5-year follow-up data from ADVANCE Japan, a nationwide prospective registry of Japanese adults aged ≥40 years with hemophilia. Participants with prior arterial thrombosis were excluded. Five-year arterial event risk was estimated using the Hisayama model, the Suita score, and QRISK3. Model performance was evaluated using sensitivity, specificity, and observed-to-expected event comparisons. Among the 599 participants (median age, 59 years; 83% hemophilia A and 63% severe disease), 28 first arterial events (4.67%) occurred over 5 years. The sensitivity and specificity for identifying events were 70.5% and 68.0% for the Hisayama model, 73.3% and 61.2% for the Suita score, and 71.4% and 57.7% for QRISK3, respectively. The observed incidence was 2.93 events per 100 participants over 5 years, closely matching predictions by the Hisayama model and Suita score, whereas QRISK3 substantially overestimated the risk. Incorporating hemophilia-related clinical factors did not improve predictive performance beyond established scores. Arterial event incidence in Japanese adults with hemophilia was comparable to that expected in the Japanese general population. The Japanese population-based risk models, the Hisayama model, may support the development of primary prevention strategies for Japanese adults with hemophilia. This trial was registered at www.jrct.mhlw.go.jp as jRCT1030190046.
引用
- Nagao A, Sawada A, Kanematsu T, et al. Cardiovascular risk scores estimate arterial thrombotic risk in aging adults with hemophilia in the ADVANCE Japan cohort. Blood Adv. 2026. PMID: 42335204. doi:10.1182/bloodadvances.2026020490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。